The Influence of Internet + Combined Family Empowerment Management Mode on Treatment Compliance of PATIENTS With CKD

Chronic Kidney Disease Clinical Trial

Official title:

The Influence of Internet + Combined Family Empowerment Management Mode on Treatment Compliance of PATIENTS With CKD and the Relationship Between Psychological Status and Disease Progression

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06167668
• Other study ID #: 2021SLL138
• Status: Recruiting
• Start date: November 23, 2023
• Est. completion date: November 24, 2024

Study information

• Verified date: December 2023
• Source: Shanxi Medical University
• Contact: Jie Zheng, Associate professor
• Phone: +8618636667799
• Email: zhengjie[@]sxmu.edu.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To explore the effect of Internet + combined family empowerment management mode on treatment compliance of patients with chronic kidney disease (CKD) and the correlation between psychological status and disease progression.

Description:

To explore the effect of Internet + combined family empowerment management mode on treatment compliance of patients with chronic kidney disease (CKD) and the correlation between psychological status and disease progression. A total of 100 patients with CKD treated in our hospital from October 2020 to October 2021 were screened and analyzed, and randomly divided into combined group and traditional group according to the number table method, with 50 patients in each group. The traditional group was implemented with the conventional chronic disease management mode, and the combined group was implemented with the Internet + combined family empowerment management mode. The differences in compliance, self-efficacy, psychological status and renal function indexes of each group were compared. Mmas-8 compliance score and GSES score showed an increasing trend. Compared with the traditional group, T2-T4MMAS-8 score and GSES score in the combined group were significantly increased with statistical differences (P < 0.05). The levels of BUN, Scr, SAS and SDS showed a decreasing trend. Compared with the traditional group, the levels of four indexes T2-T4 in the combined group were significantly decreased with statistical differences (P < 0.05). BUN, Scr were positively correlated with SAS and SDS (P< 0.05). Internet + combined family empowerment management model can effectively improve renal function, negative psychological clarity, self-efficacy and medication compliance of CKD patients, which is worthy of clinical promotion.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: November 24, 2024
• Est. primary completion date: July 24, 2024
• Gender: All
• Age group: 40 Years to 60 Years

Eligibility

Inclusion Criteria:

• Enrolled subjects meet the diagnostic criteria for CKD and are confirmed to be CKD based on laboratory findings.

• After assessment, it was determined that the subject's communication was barrier-free

• No abnormal feedback was found after evaluation.

• The patient received dialysis treatment for more than 3 months, and the clinical data were complete. This is the first time they've been to the hospital.

Exclusion criteria:

• The female patient is pregnant and lactating.

• Kidney transplant patient.

• People with language communication disorders or mental diseases.

• Participants received other psychological guidance and health education interventions during the study period.

Related Conditions & MeSH terms

• Chronic Kidney Disease
• Internet
• Kidney Diseases
• Renal Insufficiency, Chronic

Intervention

Other:
• the routine chronic disease management mode
indoor temperature and humidity adjustment, regular ventilation and hygiene of ward and clinic environment, promotion of patients' health awareness by distributing disease brochures, regular inspection of wards, and home nursing and health guidance based on disease knowledge when discharged
• the family-centered family enabling health management mode
The specific measures were as follows :(1) intervention group construction. (2) Online knowledge promotion. (3) Disease assessment.(4) Medication guidance reminder.(5) Enabling psychological counseling.

Locations

Country	Name	City	State
China	The Second Hospital of Shanxi Medical University	Taiyuan	Shanxi

Sponsors (1)

Lead Sponsor	Collaborator
Shanxi Medical University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	blood urea nitrogen	5ml of fasting elbow vein was collected from patients in the morning at four study observation time points from T1 to T4, and Z206A table top medical centrifuge produced by HERMLE, Germany, was centrifuged at a speed of 1500 r/min for 0.5h to extract upper serum, which was placed in a refrigerator at -70? for detection.	70/5000 The four observation time points in this study were 1 day before treatment, 1 month, 3 months, and 6 months after treatment, labeled T1 to T4, respectively. T1 ~ T4 when fasting in the morning.
Primary	serum creatinine	5ml of fasting elbow vein was collected from patients in the morning at four study observation time points from T1 to T4, and Z206A table top medical centrifuge produced by HERMLE, Germany, was centrifuged at a speed of 1500 r/min for 0.5h to extract upper serum, which was placed in a refrigerator at -70? for detection.	70/5000 The four observation time points in this study were 1 day before treatment, 1 month, 3 months, and 6 months after treatment, labeled T1 to T4, respectively. T1 ~ T4 when fasting in the morning.
Secondary	Morisky Medication Adherence Scale		Six months Max
Secondary	General Self-Efficacy Scale		Six months Max
Secondary	Self-Rating Anxiety Scale		Six months Max